Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Summary of post-marketing safety studies of diphtheria and tetanus toxoids and acellular pertussis vaccines (DTaP) : supplementary figures for: Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Filetype[PDF-141.81 KB]


  • Supporting Files:
    No Additional Files
You May Also Like:
  1. Literature search topics, search terms, search period, and references selected : supplementary figures for: Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). United States. Advisory Committee on Immunization Practices..
    Published Date:
    April 27, 2018
    Source:
    Liange JL, Tiwari T, Moro P, Messonnier NE, Reingold A, Sawyer M, Clark TA. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States : recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Surveill Summ 2018;67 (No. RR-2).
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 67, no. RR2
    File Type:
    Filetype[PDF - 452.12 KB]
  2. Pertussis vaccination : use of acellular pertussis vaccines among infants and young children : recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Personal Author:
    Guris, Dalya; Strebel, Peter M.; Jafari, Hamid; Wharton, Melinda; Hadler, Stephen C.;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.. National Immunization Program (Centers for Disease Control and Prevention)‏.
    Published Date:
    March 28, 1997
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1997; 46(RR-7):1-25.
    Description:
    Concerns about the safety of whole-cell pertussis vaccines prompted development of acellular vaccines that are less likely to provoke adverse events because they contain purified antigenic components of Bordetella pertussis. Two diphtheria and tetanu...
    Status:
    current
    File Type:
    Filetype[PDF - 317.63 KB]
  3. Preventing tetanus, diphtheria, and pertussis among adolescents; use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Broder, Karen R.; Cortese, Margaret M.; Iskander, John K.; Kretsinger, Katrina; Slade, Barbara A.; Brown, Kristin H.; Mijalski, Christina M.; Tiwari, Tejpratap; Weston, Emily J.; Cohn, Amanda C.; Srivastava, Pamela U.; Moran, John S.; Schwartz, Benjamin; Murphy, Trudy V.;
    Corporate Authors:
    United States, Advisory Committee on Immunization Practices.. Centers for Disease Control and Prevention (U.S.), Immunization Safety Office.. National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division..
    Published Date:
    March 24, 2006
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2006; 55(RR-3):1-34.
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 55, no. RR-3
    Description:
    During spring 2005, two tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) products formulated for use in adolescents (and, for one product, use in adults) were licensed in the United States (BOOSTRIX, GlaxoSmithKline Bi...
    Status:
    current
    File Type:
    Filetype[PDF - 473.05 KB]
  4. Timeline of Advisory Committee on Immunization Practices (ACIP) recommendations for diphtheria and tetanus toxoids and acellular pertussis vaccines (DTaP) and tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap), 1991 – 2015 : supplementary figures for: Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). United States. Advisory Committee on Immunization Practices..
    Published Date:
    April 27, 2018
    Source:
    Liange JL, Tiwari T, Moro P, Messonnier NE, Reingold A, Sawyer M, Clark TA. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States : recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Surveill Summ 2018;67 (No. RR-2).
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 67, no. RR2
    File Type:
    Filetype[PDF - 97.35 KB]
  5. Preventing tetanus, diphtheria, and pertussis among adults; use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Kretsinger, Katrina.; Broder, Karen R.; Cortese, Margaret M.; Joyce, Patricia; Ortega-Sanchez, Ismael; Lee, Grace M.; Tiwari, Tejpratap; Cohn, Amanda C.; Slade, Barbara A.; Iskander, John K.; Mijalski, Christina M.; Brown, Kristin H.; Murphy, Trudy V.;
    Corporate Authors:
    National Immunization Program (Centers for Disease Control and Prevention. Centers for Disease Control and Prevention (U.S.), Immunization Safety Office.. United States, Advisory Committee on Immunization Practices.
    Published Date:
    December 15, 2006
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2006; 55(RR-17):1-37.
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. v. 55, no. RR-17
    Description:
    On June 10, 2005, a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) formulated for use in adults and adolescents was licensed in the United States for persons aged 11--64 years (ADACEL®, manufactured by sanofi pasteu...
    Status:
    current
    File Type:
    Filetype[PDF - 418.34 KB]